Moffitt Cancer Center

Jason Brayer MD, PHD

Position
Fellow in Hematology/Oncology

Research Focus
Exploring the therapeutic potential of HDAC11 inhibitors in the treatment of multiple myeloma.
Exploring the potential for selective HDAC11 inhibitors to enhance T cell responses in the contex... Read More

Kenneth Shain, MD, PHD

Position
Dr. Kenneth Shain, MD serves as the Scientific Director of the Moffitt Myeloma Working Group (MMWG).

Research Focus
To date, Dr. Kenneth Shain, MD has been actively participating in translation research in multiple myeloma and other hematolog... Read More

Melissa Alsina, MD

Position
Head of the Multiple Myeloma Transplant Program
Associate professor of medicine in the Blood and Marrow Transplant Program

Research Focus
A specialist in multiple myeloma and bone marrow transplantation, Dr. Melissa Alsina focuses much o... Read More

Rachid C. Baz, MD

Position
Dr. Baz is a very active researcher in the field and is involved in a number of clinical trials as well as the Moffitt Myeloma Working Group (MMWG). He is a frequent lecturer on myeloma for both medical and lay audiences.

Research Focus
Dr. R... Read More

William Dalton, PHD, MD

Position
Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company. Additionally, he is founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and C... Read More

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
 

Thanks to our Myeloma Crowd Community sponsors:

.